Financial News

Markets:

Overview

News

Currencies

International

Treasuries

Corvus Pharmaceuticals, Inc. - Common Stock (NQ:CRVS)

3.950 -0.030 (-0.75%)

Streaming Delayed Price Updated: 1:00 PM EDT, Jul 3, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Corvus Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

12 Health Care Stocks Moving In Friday's Pre-Market Session

July 16, 2021

Gainers Moderna (NASDAQ:MRNA) stock increased by 7.67% to $279.6 during Friday's pre-market session. The company's market cap stands at $112.2 billion. Eton...

Via Benzinga

Corvus Pulls Plug On Mupadolimab COVID-19 Program With Candidate Now Prioritized In Oncology

July 16, 2021

Corvus Pharmaceuticals Inc (NASDAQ: CRVS) has discontinued its Phase 3 study of mupadolimab for COVID-19 due to positive trends exhibited by COVID-19 vaccines in...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session

July 13, 2021

Gainers scPharmaceuticals (NASDAQ:SCPH) ...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session

July 09, 2021

Gainers Galectin Therapeutics (NASDAQ:GALT) shares moved upwards by 47.46% to $4.07 during Friday's pre-market session. The market value of their outstanding shares is...

Via Benzinga

The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study

July 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15) IVERIC bio, Inc. (NASDAQ:...

Via Benzinga

Topics Stocks

The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs

July 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14) Alexion Pharmaceuticals,...

Via Benzinga

Topics Product Recall

Benzinga's Top Ratings Upgrades, Downgrades For May 27, 2021

May 27, 2021

Upgrades Craig-Hallum upgraded the previous rating for NVIDIA Corp (NASDAQ:NVDA) from Hold to Buy. In the first quarter, NVIDIA showed an EPS of $3.66, compared to $1.80...

Via Benzinga

The Daily Biotech Pulse: Iovance To Delay Regulatory Filing For Cancer Therapy, Departures At Passage Bio, Positive Readout For Silence Therapeutics

May 19, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 18) Alexion Pharmaceuticals, Inc...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday

May 18, 2021

Before 10 a.m. ET on Tuesday, 8 companies hit new 52-week lows. Areas of Significance: Canadian Pacific Railway (NYSE:CP) was the biggest company by market cap to...

Via Benzinga

The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO

May 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 17) Alexion Pharmaceuticals, Inc...

Via Benzinga

The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron

May 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Financial News

Corvus Pharmaceuticals, Inc. - Common Stock (NQ:CRVS)

All News about Corvus Pharmaceuticals, Inc. - Common Stock

Popular Pages